← Back to all trials
Not Yet Recruiting
NCT05703282
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
Conditions: Hyperlipidemias
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 32
Sponsor: Addpharma Inc.
Location: Korea, Republic of
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-104-A
Eligibility Criteria
Inclusion Criteria:For all subjectsAdults aged 19 years and olderBody mass index(BMI) of 18 to 30 kg/m2Voluntarily given written informed consentFor renal Impairment subjects30 ≤ eGFR < 90 mL/min/1.73m^2For healthy subjectseGFR ≥ 90 mL/min/1.73m^2Exclusion Criteria:Participation in another clinical study with an investigational drug within the 6 months from scheduled first administrationOther exclusions applied
Source: ClinicalTrials.gov (NCT05703282). StuddyBuddy aggregates publicly available trial information.
